Cargando…

Rates of Decline in Alzheimer Disease Decrease with Age

Age is the strongest risk factor for sporadic Alzheimer disease (AD), yet the effects of age on rates of clinical decline and brain atrophy in AD have been largely unexplored. Here, we examined longitudinal rates of change as a function of baseline age for measures of clinical decline and structural...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holland, Dominic, Desikan, Rahul S., Dale, Anders M., McEvoy, Linda K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410919/ https://www.ncbi.nlm.nih.gov/pubmed/22876315 http://dx.doi.org/10.1371/journal.pone.0042325

Ejemplares similares

Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials
por: Holland, Dominic, et al.
Publicado: (2012)

Combining Polygenic Hazard Score With Volumetric MRI and Cognitive Measures Improves Prediction of Progression From Mild Cognitive Impairment to Alzheimer's Disease
por: Kauppi, Karolina, et al.
Publicado: (2018)

Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
por: Desikan, Rahul S, et al.
Publicado: (2013)

Cognitive Phenotypes, Brain Morphometry and the Detection of Cognitive Decline in Preclinical AD
por: Jacobson, Mark W., et al.
Publicado: (2009)

Modifying the minimum criteria for diagnosing amnestic MCI to improve prediction of brain atrophy and progression to Alzheimer’s disease
por: Vuoksimaa, Eero, et al.
Publicado: (2018)

Insulin-Like Growth Factor Binding Protein 2 Is Associated With Biomarkers of Alzheimer’s Disease Pathology and Shows Differential Expression in Transgenic Mice
por: Bonham, Luke W., et al.
Publicado: (2018)

Microstructural brain changes track cognitive decline in mild cognitive impairment
por: Reas, Emilie T., et al.
Publicado: (2018)

Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease
por: McGrattan, Andrea M., et al.
Publicado: (2019)

Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score
por: Desikan, Rahul S., et al.
Publicado: (2017)

THE RANCHO BERNARDO STUDY (RBS) OF HEALTHY AGING: A RICH RESOURCE FOR STUDYING AGING IN WOMEN
por: McEvoy, Linda, et al.
Publicado: (2019)

Brain microstructure mediates sex-specific patterns of cognitive aging
por: Reas, Emilie T., et al.
Publicado: (2021)

Genetic Sharing with Cardiovascular Disease Risk Factors and Diabetes Reveals Novel Bone Mineral Density Loci
por: Reppe, Sjur, et al.
Publicado: (2015)

Effects of polygenic risk for Alzheimer’s disease on rate of cognitive decline in normal aging
por: Kauppi, Karolina, et al.
Publicado: (2020)

Rates of Cognitive Decline in 100 Patients With Alzheimer Disease
por: Miyakawa-Liu, Monica, et al.
Publicado: (2022)

Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate
por: Andreassen, Ole A., et al.
Publicado: (2013)

Correction: Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate
por: Andreassen, Ole A., et al.
Publicado: (2015)

Age‐dependent effects of APOE ε4 in preclinical Alzheimer's disease
por: Bonham, Luke W., et al.
Publicado: (2016)

Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
por: Reas, Emilie T., et al.
Publicado: (2017)

Cognitive Declines Precede and Predict Functional Declines in Aging and Alzheimer’s Disease
por: Zahodne, Laura B., et al.
Publicado: (2013)

Reversal of cognitive decline in Alzheimer's disease
por: Bredesen, Dale E., et al.
Publicado: (2016)

Subjective cognitive decline and rates of incident Alzheimer’s disease and non-Alzheimer’s disease dementia
por: Slot, Rosalinde E. R., et al.
Publicado: (2018)

Mapping the gene network landscape of Alzheimer’s disease through integrating genomics and transcriptomics
por: Rosenthal, Sara Brin, et al.
Publicado: (2022)

Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer’s Disease
por: Gottesman, Reena T., et al.
Publicado: (2019)

Abundant Genetic Overlap between Blood Lipids and Immune-Mediated Diseases Indicates Shared Molecular Genetic Mechanisms
por: Andreassen, Ole A., et al.
Publicado: (2015)

Correction: Abundant Genetic Overlap between Blood Lipids and Immune-Mediated Diseases Indicates Shared Molecular Genetic Mechanisms
por: Andreassen, Ole A., et al.
Publicado: (2015)

The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
por: Bonham, Luke W., et al.
Publicado: (2016)

Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus
por: Desikan, Rahul S., et al.
Publicado: (2015)

Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease
por: Qian, Jing, et al.
Publicado: (2021)

Causal association of cognitive reserve on Alzheimer's disease with putative sex difference
por: Wang, Hao, et al.
Publicado: (2021)

Beyond SNP heritability: Polygenicity and discoverability of phenotypes estimated with a univariate Gaussian mixture model
por: Holland, Dominic, et al.
Publicado: (2020)

Similar Genetic Architecture of Alzheimer’s Disease and Differential APOE Effect Between Sexes
por: Wang, Hao, et al.
Publicado: (2021)

Glia and zinc in ageing and Alzheimer’s disease: a mechanism for cognitive decline?
por: Hancock, Sara M., et al.
Publicado: (2014)

Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease
por: Desikan, Rahul S., et al.
Publicado: (2010)

Decreased Tuberculosis Incidence and Declining Clustered Case Rates, Madrid
por: Iñigo, Jesús, et al.
Publicado: (2008)

Current Alzheimer disease research highlights: evidence for novel risk factors
por: Brenowitz, Willa D., et al.
Publicado: (2021)

Thyroid Antibodies, Autoimmunity and Cognitive Decline: Is There a Population-Based Link?
por: Napthali, Kate, et al.
Publicado: (2014)

Epigenetic Mechanisms in Memory and Cognitive Decline Associated with Aging and Alzheimer’s Disease
por: Maity, Sabyasachi, et al.
Publicado: (2021)

Is the risk of Alzheimer’s disease and dementia declining?
por: Langa, Kenneth M
Publicado: (2015)

Structural Neuroimaging in the Detection and Prognosis of Pre-Clinical and Early AD
por: Fennema-Notestine, Christine, et al.
Publicado: (2009)

Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease
por: McKee, Chloe G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2airp0po7lsc99f3aulc31q84o